SYNERGY-AI

Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Targeted Disease(s):
Lung Cancer

Purpose of Study:

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical trial enrollment (CTE), as well as the financial impact, and potential outcomes of the intervention.

Study Dates:
January 1, 2018 - December 1, 2022

Study Design:
Observational Design

Study Location:
Nationwide

Lead Institution:
Massive Bio, Inc.

ClinicalTrails.gov Identifier:
NCT03452774

Register for Trial
LUNG FORCE Community Connections: Lung Cancer & COPD
, | Dec 07, 2021
Lung Mind Alliance Convening
, | Dec 08, 2021